# Purified Inactivated Japanese Encephalitis Vaccine

> **NCT04223037** · PHASE3 · UNKNOWN · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 1050 (actual)

## Conditions studied

- Japanese Encephalitis Virus Disease

## Interventions

- **BIOLOGICAL:** Japanese Encephalitis Vaccine produced by IMBCAMS
- **BIOLOGICAL:** Japanese Encephalitis Vaccine produced by Liaoning Chenda

## Key facts

- **NCT ID:** NCT04223037
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09-01
- **Primary completion:** 2018-03-07
- **Final completion:** 2022-12-31
- **Target enrollment:** 1050 (ACTUAL)
- **Last updated:** 2022-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04223037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04223037, "Purified Inactivated Japanese Encephalitis Vaccine". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04223037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*